Report Categories
View AllRecent Articles
View All
KTTA Pasithea Therapeutics shares climb 21 percent despite reporting a far wider than expected Q4 2025 per share loss
PetMed Express PETS Competitive Edge Q1 2026 Earnings Fall Short
What Anavex AVXL is doing to expand margins Q1 2026 Profit Surprises
What should investors watch next for Quoin QNRX stock Q4 2025 Profit Exceeds Views